About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Monthly Archives: September 2007
Weekly Roundup – 9-7-07
Congress is back. They take up more room inside the Beltway. That means traffic, among other things. School is in. More traffic. We are all back in the saddle again. The heat of summer seems to have gotten the hint … Continue reading
Posted in Weekly Roundup
Comments Off on Weekly Roundup – 9-7-07
Report on Medicare Part D
As the Medicare Part D experience completed its first year, there have been a number of opinions expressed on how well the benefit did what it set out to do – provide seniors with a benefit on prescription drug access. … Continue reading
Posted in REimbursement
Comments Off on Report on Medicare Part D
Social Media and Pharmaceutical Marketing
On several occasions in the past, I have posted here on the need for pharmaceutical companies to embrace new and social media, along with several suggestions for doing so. One of the perceived barriers to the involvement of pharmaceutical companies, … Continue reading
Posted in Marketing, Regulatory Communications, Social Media, Useful Resources
Comments Off on Social Media and Pharmaceutical Marketing
Unfinished Business – Legislative Imperatives for September
Congress is back from recess. Quite a lively recess it was too, if you read the papers. As tempting as it is to weigh in on that, I’ll go on to other matters. First of all, SCHIP – the State … Continue reading
Posted in Legislation
Comments Off on Unfinished Business – Legislative Imperatives for September
FDA’s Dr. Janet Woodcock Discusses Adaptive Clinical Trials
We are all trying to re-enter the workforce after August. Here in the Beltway, the Congress is headed back and the traffic congestion returns as students everywhere return to school. Labor Day Weekend has passed and alas, I have put … Continue reading
Posted in Podcast
Comments Off on FDA’s Dr. Janet Woodcock Discusses Adaptive Clinical Trials